A patient with diabetes touches several clinicians. The endocrinologist reviews glycemic control, primary care screens blood pressure and kidney function, the ophthalmologist documents the eye exam, and the podiatrist checks the feet. Each task maps to a different Quality measure, and a mismatched set can waste a reporting year.
CMS finalized the Diabetic Disease MIPS Value Pathway for the 2027 performance period, which corresponds to the 2029 MIPS payment year. It gives primary care, endocrinology, ophthalmology, podiatry, and nonphysician practitioners one diabetes-focused measure set. This guide covers who should evaluate it, which measures belong to each clinical grouping, and how to organize the workflow. For the bigger picture first, read our overview of understanding the 2027 MIPS Value Pathways framework.
What Is the Diabetic Disease MVP?
The Diabetic Disease MVP is a condition-based pathway. CMS selected measures and activities already in the MIPS inventory that best fit diabetic disease care, and the CMS 2027 Finalized MVPs Guide describes the pathway as assessing meaningful outcomes in that care.
Each performance category reflects the same clinical concept. Quality measures address glycemic status, kidney health, preventive screening, and specialty care such as eye and foot exams. Two cost measures relate diabetes care to Medicare spending. Improvement Activities center on chronic care management, lifestyle support, and glycemic management. Promoting Interoperability follows the measures required under traditional MIPS, unless a clinician qualifies for reweighting.
Traditional reporting lets a practice assemble six unrelated Quality measures. Here, the measures, cost, and activities describe one patient population, so documentation work lines up across categories.
Who Should Consider the Diabetic Disease MVP in 2027?
CMS says clinicians in primary care, endocrinology, ophthalmology, podiatry, and nonphysician practitioners, such as clinical nurse specialists, nurse practitioners, and physician assistants, may want to consider this MVP. That wording is a suggestion, not an eligibility rule.
Treat diabetes MIPS eligibility as three separate questions. Does CMS identify your specialty as a possible fit? Does the clinician meet MIPS eligibility requirements, which our guide to complete MIPS reporting requirements for 2027 covers? And does your practice have enough diabetes-related clinical activity and reportable data to use the pathway well?
Consider a family medicine group where two physicians manage large diabetic panels and a third works mostly in urgent care. The pathway may suit the first two far better than the third. Review each clinician’s responsibilities, patient population, reporting structure, and measure applicability before committing.
2027 Diabetic Disease MVP Quality Measures
The CMS guide designates four MIPS Core Measures within this MVP.
| Measure ID | Measure name | Clinical relevance |
|---|---|---|
| Q001 | Diabetes: Glycemic Status Assessment Greater Than 9% | Glycemic status assessment |
| Q128 | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan | BMI screening and follow-up |
| Q317 | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented | Blood pressure screening |
| Q488 | Kidney Health Evaluation | Kidney health monitoring |
These are not four additional measures. MVP participants submit four Quality measures, and one must be a Core Measure from the chosen MVP. The four above are your options for that single slot. A clinician with no applicable Core Measure must attest to that and report another measure from the MVP instead. The 2027 MIPS Core Measure requirements explain the policy in full.
The other three measures come from the clinical groupings. Q001 and Q488 sit in the multispecialty grouping, while Q128 and Q317 sit in Advancing Health and Wellness. Q128 and Q317 are preventive screening measures, so confirm each denominator in the specification instead of assuming it matches your diabetic panel.
Specialty-Specific Measure Selection Within the Diabetic Disease MVP
Availability depends on the clinical grouping and, within it, the collection type. A measure offered through one collection type is not necessarily offered through another.
| Clinical grouping | Measure | Collection type |
|---|---|---|
| Ophthalmology | Q019: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care | eCQM |
| Ophthalmology | Q117: Diabetes: Eye Exam | eCQM, MIPS CQM |
| Ophthalmology | IRIS58: Improved Visual Acuity after Vitrectomy for Complications of Diabetic Retinopathy within 120 Days | QCDR |
| Podiatry | Q126: Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation | MIPS CQM |
| Podiatry | Q127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear | MIPS CQM |
| Podiatry | USWR35: Adequate Off-loading of Diabetic Foot Ulcers performed at each visit, appropriate to location of ulcer | QCDR |
| Multispecialty | Q001: Diabetes: Glycemic Status Assessment Greater Than 9% | eCQM, MIPS CQM, Medicare Part B Claims |
| Multispecialty | Q438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | eCQM, MIPS CQM |
| Multispecialty | Q488: Kidney Health Evaluation | eCQM, MIPS CQM |
| Advancing Health and Wellness | Q128, Q134 (Screening for Depression and Follow-Up Plan), Q226 (Tobacco Use: Screening and Cessation Intervention), Q317 | Each available through eCQM, MIPS CQM, and Medicare Part B Claims |
Primary Care and Multispecialty Diabetes Reporting
Q001 tracks patients whose glycemic status exceeds 9%, so a lower rate reflects better performance. Confirm how your EHR displays that result before anyone reads a dashboard. Q488 depends on kidney function and urine albumin testing results that must exist in the record as usable data. Q438 addresses statin therapy for cardiovascular disease prevention and treatment. Its eligible population comes from the specification, so verify which diabetic patients fall into the denominator.
Together, these measures follow one patient across visits and labs. A practice reports them well only when outside lab results reach the chart in a form the EHR can count.
Ophthalmology Measures
Q019 asks whether retinal findings reached the physician managing the patient’s diabetes, and it is collected only as an eCQM. IRIS58 covers visual acuity within 120 days after vitrectomy for diabetic retinopathy complications, so it applies to a narrow surgical population.
Coordination matters because an eye exam helps only when the clinician managing diabetes sees it. Record the date and recipient of each communication. Ophthalmologists should also note that Q019, Q117, and IRIS58 appear in the separate Complete Ophthalmologic Care MVP, so compare both pathways.
Podiatry Measures
Foot-focused templates should capture the neurological evaluation, the footwear assessment, and, for ulcer care, the ulcer location with the off-loading approach at every visit. Q126 and Q127 run through MIPS CQM, while USWR35 runs through a QCDR, so one podiatry workflow can involve two reporting routes. The guide lists no cost measure beside the podiatry grouping, and CMS also maintains a separate Podiatry MVP worth comparing.
Diabetic Disease MVP Cost Measures Explained
The guide lists two cost measures: COST_D_1 (Diabetes) and TPCC_1 (Total Per Capita Cost). COST_D_1 is the diabetes-specific measure, while TPCC_1 reflects total per capita cost across a patient’s care. Both appear beside the multispecialty and Advancing Health and Wellness groupings, and the ophthalmology and podiatry groupings list none.
Cost works differently from Quality. You do not select or submit it. CMS calculates cost performance from applicable administrative claims data, using only the cost measures in the MVP. Because claims decide which patients and spending count, practices benefit from knowing their diabetic panel, referral patterns, and where patients receive labs, imaging, and hospital care. Review any CMS performance feedback available to you, and check each measure’s specification for attribution details.
Improvement Activities Available in the Diabetic Disease MVP
The guide lists 13 activities, and several map directly to diabetes care. IA_AHW_1: Chronic Care and Preventative Care Management for Empaneled Patients and IA_CC_9: Implementation of practices/processes for developing regular individual care plans support care coordination. IA_AHW_5: Lifestyle Approaches to Diabetes Remediation, new for 2027, and IA_PM_4: Glycemic Management Services support lifestyle and glycemic work. IA_BE_19: Use group visits for common chronic conditions and IA_BE_23: Integration of patient coaching practices between visits support patient education between appointments. These are examples, not the full inventory.
Clinicians, groups, and subgroups must attest to one activity, and it must come from this MVP’s list. Choose one your team actually performs, and keep dated records such as protocols, schedules, or attendance logs in case CMS asks.
Documentation and Data Collection for Diabetes MIPS Reporting
Measure results are only as accurate as the chart. A numerator counts a patient only when the record shows the required action, and a denominator depends on correct diagnoses and encounter data. Missing documentation does not mean care did not happen. It means the measure cannot show it.
Familiar gaps look like this. A glycemic result sits in a scanned outside lab instead of a structured field. A BMI is recorded while the follow-up plan lives in free text the EHR cannot read. A blood pressure reading has no documented follow-up. Kidney labs arrive from a reference lab outside the interface. An ophthalmology letter reaches the diabetes care provider without a dated entry. Podiatry clinicians document neurological evaluations and footwear assessments in different formats, and off-loading notes omit ulcer location.
EHR configuration solves most of this: structured fields, standard templates, and lab interfaces. Confirm each measure’s collection type before designing a workflow, because eCQM, MIPS CQM, QCDR, and claims pull data differently. Validate during the year, monthly or quarterly, rather than at submission. When you share patient data with a registry or reporting vendor, confirm a HIPAA business associate agreement is in place.
How to Prepare Your Practice for the 2027 Diabetic Disease MVP
- Confirm which clinicians are MIPS eligible and how your group reports.
- Compare the pathway with each specialty’s real diabetic panel.
- Identify the clinical grouping that matches each clinician’s work.
- Check every shortlisted measure’s collection type against what your EHR or registry supports.
- Map each measure’s numerator and denominator elements to specific chart fields.
- Confirm your EHR or registry can report the chosen measures.
- Schedule recurring data validation and assign an owner.
- Review claims-based cost information when CMS makes it available.
- Select an Improvement Activity and begin saving evidence.
- Review progress well before the submission period.
Start early in the performance year. A template gap found in spring can be fixed while patients are still being seen. A gap found after December cannot.
When Should a Practice Evaluate Professional MIPS Reporting Support?
Several diabetes measures across specialties can strain an administrative team. Practices commonly need help with measure applicability reviews, quality data validation, consistent documentation across clinicians, EHR and registry coordination, reporting workflow management, and preparing the CMS submission.
Proactive Healthcare Services offers MIPS Value Pathways reporting support for practices that want help with these tasks. We do not promise scores or payment outcomes. The aim is accurate, well-documented reporting.
Looking for reliable MIPS reporting support for your healthcare practice? Connect with Proactive Healthcare Services to discuss your reporting workflows, measure selection, and data validation needs.
Frequently Asked Questions
What is the Diabetic Disease MVP for 2027?
It is a condition-based MIPS Value Pathway that begins with the 2027 performance period (2029 payment year). It groups diabetes-related Quality measures, two cost measures, and Improvement Activities.
Which medical specialties can consider reporting the Diabetic Disease MVP?
CMS names primary care, endocrinology, ophthalmology, podiatry, and nonphysician practitioners such as clinical nurse specialists, nurse practitioners, and physician assistants. Being named does not establish MIPS eligibility.
What are the four Core Measures in the 2027 Diabetic Disease MVP?
Q001 (Glycemic Status Assessment Greater Than 9%), Q128 (BMI Screening and Follow-Up Plan), Q317 (Screening for High Blood Pressure and Follow-Up Documented), and Q488 (Kidney Health Evaluation).
How many Quality measures must be reported under the Diabetic Disease MVP?
Four, including one MIPS Core Measure. If none applies to you, attest to that and report another MVP measure in its place.
Which cost measures are included in the Diabetic Disease MVP?
COST_D_1 (Diabetes) and TPCC_1 (Total Per Capita Cost). CMS calculates both from administrative claims, so you submit nothing for them.
What documentation should practices maintain for diabetes-related MIPS measures?
Keep dated source records for each measure element: glycemic and kidney results, BMI with follow-up plan, blood pressure with follow-up, eye exam communications, foot evaluations, footwear assessments, and off-loading notes. Add evidence for your chosen Improvement Activity.
Conclusion: Preparing for Diabetes-Focused MIPS Reporting
Diabetic Disease MVP 2027 reporting rewards practices that match measures to what their clinicians actually do. Start with the clinical grouping, verify collection types, and build documentation that the EHR can count. Review that data throughout the year, and the submission period becomes a check instead of a scramble. For finalized policy details, see the finalized MIPS changes for 2027.
Need help organizing your diabetes reporting? Contact Proactive Healthcare Services to discuss your administrative support requirements.
